Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders.

@article{Panzer2005ImplicationsOA,
  title={Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders.},
  author={Pat Ellen Panzer and Timothy S Regan and Evelyn F. Chiao and Matthew W Sarnes},
  journal={The American journal of managed care},
  year={2005},
  volume={11 12 Suppl},
  pages={S370-9}
}
As the antidepressant market continues to expand, it is important for healthcare decision makers to develop clinically and economically sound drug benefit designs. As such, the purpose of this study was to determine the economic implications of a generic step therapy (GST) formulary compared with an open formulary for selective serotonin reuptake inhibitors (SSRIs) in patients with anxiety disorders. A model simulating the SSRI treatment patterns of patients diagnosed with an anxiety disorder… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…